The burgeoning popularity of semaglutide , initially for metabolic conditions, is creating significant buzz within the United Kingdom , prompting a notable shift in medication trends. Obtaining these medications remains a complex landscape, with NHS coverage currently limited and independent providers offering treatment at a premium . Concerns are